New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

Prostate cancer: A new type of radiation treatment limits risk of side effects - Harvard Health

Scientists find possible genetic key to why some lymphoma patients don't respond to treatment

Taking Supplements During Breast Cancer Treatment Increases Risk Of Death And Relapse, What Does This Mean For Patients?

Lynne Pearce, Page 12

These New Cancer Drugs Improve Outcomes for People with Hard-to-Treat Tumors

For some cancer patients, precision medicine offers hope – and possibility of financial ruin

Cancer patients 'at risk' due to treatment delays, doctors say

Experts call for patients to access cancer treatment without delay despite Covid pandemic

Clinical update, Cancer Nursing Practice

Clinical update, Cancer Nursing Practice

Cancer Causes, Symptoms, Diagnosis, Treatment, and More

Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy, Study Finds

PSMA-therapy with Actinium-225